GLP-1 medications offer myriad benefits and have changed how many people view and treat obesity. Dr. Sanjay Gupta explains how these medications work, how they help with weight loss, and why they’re not meant to be a stand-alone treatment. GLP-1 medications should always be used along with lifestyle intervention and under clinical supervision for safety and efficacy. At Form Health, every patient partners with a dedicated Care Team which includes an ABOM physician and a speicalized Registered Dietitian. Together, they create a personalized plan that addresses behavioral health, nutrition, physical activity, and may include a prescription for FDA-approved medication, when appropriate. This comprehensive approach helps patients achieve their weight loss and health goals. Working closely with medical experts ensures treatment plans are safe, adaptable, and effective for sustained success. Are you looking for a partner to deliver an obesity solution that leverages the latest science for sustainable weight loss and improved health, all while controlling costs? Contact us at [email protected] to learn how we can help.https://https://lnkd.in/e-vwRZDP
Form Health
医院和医疗保健
Boston，Massachusetts 4,778 位关注者
Form Health is the national leader in science-based obesity care.
关于我们
Form Health is the national leader in science-based obesity care. Our clinical care model consists of one-on-one, personalized care from a dedicated ABOM-certified physician and a CSOWM-certified Registered Dietitian, who develop individualized treatment plans that address behavioral health, nutrition, physical activity, and include a prescription for FDA-approved medication, if appropriate. Form Health keeps safety, efficacy, and outcomes at the forefront as we incorporate the latest research and science into our approach. This means we’re always innovating, constantly getting smarter about the science of obesity care, relentlessly focusing on exceptional results, and calling out harmful practices that hold back progress. The result is life-changing outcomes for our patients and meaningful ROI for our enterprise partners. Form Health is in-network with national health plans. Learn more at formhealth.co.
- 网站
-
https://formhealth.co
Form Health的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 51-200 人
- 总部
- Boston，Massachusetts
- 类型
- 私人持股
- 创立
- 2019
地点
-
主要
获取路线
109 State St
5th Floore
US，Massachusetts，Boston，02109
Form Health员工
动态
-
Form Health Chief Medical Officer Florencia Halperin highlights the groundbreaking findings from the SURMOUNT-1 trial.Patients living with obesity and prediabetes achieved an average 19.7% weight loss and experienced a 93% decrease in the risk of progressing to type 2 diabetes after three years.These results underscore the impact that using clinical tools to address both obesity and diabetes can have on individual health and broader population outcomes. As employers face rising healthcare costs, it’s clear that cardiometabolic diseases—such as obesity and type 2 diabetes—are among the most expensive chronic conditions. Clinical evidence like this increasingly shows that treating obesity first can lead to cost savings and significantly improve employee health outcomes. Form Health helps patients achieve their weight and health goals while addressing the high costs of obesity and cardiometabolic conditions. Are you an employer looking for a partner to provide an obesity solution that utilizes the latest science to deliver sustainable weight loss and improved health while controlling costs? Contact us at [email protected] to learn how we can help.
The results of the 3-year outcomes of treatment with the GLP1/GIP dual agonist tirzepatide are out, and the data are impressive and impactful. At 176 weeks, the study participants with both?obesity and prediabetes on the?15-mg (highest) dose?lost an average of 19.7% of their weight. Besides some GI side effects, there were no major safety signals. And the delay in progression to type 2 diabetes from the high risk state of prediabetes was incredible. In the tirzepatide group only 1.3% progressed over 176 weeks, compared to 13.3% in the placebo group. A 93% reduction in risk, in just 3 years of follow up. It is a huge leap forward to have clinical tools that address both obesity management and diabetes prevention so effectively.?A markedly lower progression to type 2 diabetes has incredible clinical impact for individuals. It also has important economic implications. Type 2 diabetes is one of the most costly diseases. Medical expenses from employees with diabetes are about double compared to those without, and it is estimated US?employers lose more than $20 billion annually due to unplanned missed days of work by?employees with diabetes.?So although this study did not look at ROI, these data are critical as we build the case(s) for the imperative to treat obesity?-- as a way to prevent, and avoid the innumerable costs, of cardiometabolic disease.
-
Form Health physician Lauren Lemieux, MD, FACP, DABOM emphasizes the importance of personalized treatment plans for patients with obesity. Each individual is unique and a therapy that works for one person may not work for another for a variety of reasons. Providers must recognize when something isn't working, explore other treatment options, and provide compassionate care so patients understand it's not their fault if a treatment doesn't work. At Form Health, we provide non-judgmental, science-based obesity care that is tailored to each patient’s unique needs to help them achieve their weight loss and health goals. Our ABOM-certified physicians and CSOWM Registered Dietitians refine treatment plans as needed to ensure optimal outcomes for each patient. Interested in learning how we can help your organization deliver life-changing patient outcomes while controlling costs? Reach out to us at [email protected].
There is a subset of patients considered “non-responders” to therapy in clinical trials; however, I propose we look at it from the perspective of *the therapy is not working* for this patient (rather than the patient is not responding). So why does this occur even with these so-called “miracle drugs?” It all boils down to the fact that there are important differences among individuals that will effect outcomes of treatments for obesity, whether that be lifestyle changes, medications or surgery. We cannot forget that we are treating individuals and need to be versatile to utilize other tools in the toolbox to find what works with this unique patient. This article also reminds us to consider whether the clinical trial population is or is not similar to the individual patient being treated. In the future, I believe we will have better ways to identify the best treatment for each individual. Until we have better guidance, remember that if the treatment is not working for the patient, don’t be afraid to make a change, and let’s support the patient with the knowledge that it is not their fault if a medication is not the right fit. https://lnkd.in/gK2PiSwE
Are GLP-1 drugs really for everybody? - Nature Medicine
nature.com
-
Check out the team from Sound Ventures, on stage at TechCrunch Disrupt,?where Effie Epstein discusses why they invested in Form Health and how our approach to virtual obesity care is setting a new standard. Starts at 2:30.
Making sound investments in 2024 with Ashton Kutcher | TechCrunch
https://techcrunch.com
-
Form Health physician Lauren Lemieux, MD, FACP, DABOM shares highlights from #ObesityWeek, including the role of precision nutrition in obesity treatment. Nutrition therapy can play a key role in helping patients achieve weight loss and improved health. At Form Health, each patient works with a Registered Dietitian who is a Certified Specialist in Obesity and Weight Management (CSOWM). This specialist works with the patient to develop a personalized nutrition therapy plan tailored to the patient’s health goals and preferences with a focus on developing healthy eating habits and adopting sustainable changes. As employers evaluate obesity solutions, it's important to ensure participants receive the comprehensive support required for sustained results. Form Health patients work with an ABOM-certified physician and a CSOWM dietitian who collaborate to create a treatment plan that addresses behavioral health, nutrition, and physical activity along with a prescription for FDA-approved medication, as appropriate. Are seeking a partner to deliver an obesity solution that uses the latest science to achieve sustainable weight loss and improved health while controlling cost? Contact us at [email protected] to learn how we can help.
"Studying food is much more complex than any drug out there” was a clear message from my colleague and mentor Dr. Zhaoping Li, MD, PhD that she shared at her #OW2024 talk “Is Precision Nutrition Ready for Prime Time in Obesity Care?”? The complexity of food (and food science) is related to many factors including the fact that we do not eat single nutrients, meals typically consist of different foods in combination, foods are prepared in different ways, and our bodies process foods differently.? She shared some of the many ways personalized nutrition research has the potential to revolutionize our health, and here are just a few of the hot topics she touched on: - How different biomarkers are influenced by the foods we eat (and how can we might measure these easily): https://lnkd.in/g4c44mRs - How the timing of when we eat (chrononutrition) impacts our health: https://lnkd.in/gPQv87i8 - How foods we eat impact our individual gut microbiome.?? --- Spices: https://lnkd.in/gAmifZz7 --- Nonnutritive sweeteners: https://lnkd.in/guyF5DX4
-
-
Chief Medical Officer, Florencia Halperin recaps the Obesity (R)evolution panel that she participated on as part of #ObesityWeek, sharing insights from her copanelists and highlighting the alignment with Form Health’s approach to scaling obesity care. Key highlights: 1.) Impactful non-GLP-1 medications can drive meaningful health outcomes in a cost-effective way, 2.) Telehealth can expand access by providing flexibility and enhancing engagement, 3.) Ongoing clinical education is critical in a field that is changing rapidly. Are you an employer looking for a partner to provide an obesity solution that applies the latest science and evidence to deliver sustainable weight loss and improved health while controlling costs? Contact us at [email protected] to learn how we can help.
The Obesity Society's #ObesityWeek 2024 was so energizing and inspiring! I was so grateful to speak on the Obesity (R)evolution panel moderated by Dr. Deborah Bade Horn, alongside Drs. Terry Wickham and Sarah Ro. I was especially inspired by Dr. Ro's work scaling access to obesity care in an underserved rural patient population, mostly covered by Medicaid. Dr. Ro has taken such an innovative and creative approach in the University of North Carolina health system, and I found so much alignment with what we do at Form Health. ? Severity/Risk stratification. Her (and her team's) model uses obesity severity to triage patients to different access points and interventions. They successfully serve all patients, not just those who have coverage for GLP1 receptor agonists, by combining effective science-based lifestyle support and prescribing across a range of pharmacotherapy that can support weight loss and metabolic health. In fact, the top two medications used are #metformin and #topiramate. We too have seen that using a broad spectrum of medications can drive impactful health gains and in a more cost-controlled way. I am going to steal a "clinical pearl" from her: While we all know that newer AOMs are more effective on average than older meds, she helps patients on the lower end of the severity spectrum feel optimistic about the health results they can accomplish by counseling that you don't always need to "shoot a fly ?? with a cannonball ??" -- with non-GLP1 options we can still see impactful results. I loved this! ? Leveraging telehealth. Her program offers in person and telehealth visits, so that patients can have greater flexibility and engagement. The patient case she presented was someone who started out with very little mobility, difficulty getting to appointments and unable to work. It was so inspiring to see a photo after treatment, of the patient standing next to Dr Ro in an elegant dress, now able to work thanks to weight loss driving such health improvements! ? Ongoing clinician education and learning. Dr. Ro won institutional support to cover ABOM certification for clinicians and help them deepen their expertise and serve patients more effectively. She highlighted that a greatly appreciated perk for these clinicians is an ongoing monthly educational conference. At Form, our clinical team gets together virtually once monthly for a journal club and once monthly for a clinical case conference. With our our commitment to evidence-based practice and our field changing so rapidly, this is so important. These conferences --where I learn from my amazing colleagues-- are also a top highlight for me personally! It's so exciting to learn what others are doing to expand access to effective obesity care. Stay tuned for more insights from #ObesityWeek 2024 - so much to digest and share!
-
-
Form Health physician, Lauren Lemieux, MD, FACP, DABOM, presented new findings at #ObesityWeek presented by The Obesity Society. The study was completed in collaboration with researchers at David Geffen School of Medicine at UCLA and demonstrated improved weight loss outcomes from Endoscopic Bariatric Therapy (EBT) when paired with specialized care from a telehealth obesity clinic. The prospective observational study found that patients referred to Form Health after EBT achieved greater weight loss at 12 months compared to those who did not receive teleheatlh obesity medicine follow-up care. Increased weight loss likely resulted from the specialized obesity care provided by an ABOM-certified physician and a CSOWM-credentialed Registered Dietitian. This dedicated Care Team created a personalized plan for each patient that addresses behavioral changes, nutrition, physical activity, and FDA-approved medications, if appropriate. These findings underscore that obesity is a complex, chronic disease requiring comprehensive and individualized care for lasting success. One procedure alone is rarely sufficient—sustained weight loss often requires ongoing treatment leveraging other tools like lifestyle intervention and FDA-approved medication. How can you best support members who receive bariatric care? Support their long-term success by offering benefits that promote sustained health improvements and reduced risk of weight regain. Form Health helps patients achieve their weight and health goals address while addressing the high costs of obesity and cardiometabolic conditions. Contact us at [email protected] to learn how we can help.
-
-
Attending the St. Louis Area Business Health Coalition event today? Stop by to say hello to Jen Cressman and learn how Form Health is helping organizations provide science-based obesity care that improves cardiometabolic health while controlling costs. We'd love to share how we can help your members achieve life-changing weight loss and deliver ROI. Not attending but want to learn more? Email us at [email protected].
-
-
Form Health physicians Beth Marshall, DO, Dipl. ABOM and Florencia Halperin presented their findings “Real-World Analysis of Semaglutide Outcomes in a Telehealth Obesity Medicine Clinic” at #ObesityWeek presented by The Obesity Society. Their analysis demonstrated that virtually-delivered intensive lifestyle therapy combined with semaglutide led to clinically meaningful weight loss of 8.4%, 13.6%, and 17.7% at 6, 12, and 18 months, respectively. These findings highlight the effectiveness of Form Health's virtual care model in achieving meaningful real world results by pairing a GLP-1 medication with high intensity lifestyle interventions delivered by obesity specialists. As employers consider covering GLP-1 medications, it's imperative to also provide members with the specialized wraparound clinical care required to achieve meaningful and sustained results. Comprehensive care not only improves patient outcomes, but also lowers the overall cost of healthcare and delivers ROI for your investment. Let us show you how Form Health can help your organization provide a clinical obesity solution that maximizes the impact of GLP-1s to change patient lives while maximizing ROI. Contact us at [email protected].
-
-
If you're at #ObesityWeek today don't miss Dr. Florencia Halperin! She is on the agenda with her presentation, Obesity Care (R)evolution, where she will discuss models of obesity care delivery and how to best support patients living with obesity today at 8:00 to 9:30 AM in Room 214.
I am thrilled to be at ObesityWeek? 2024! If you are here, come check out my session on the Obesity Care (R)Evolution on Tuesday at 8a CST.
-